Calprotectin Serum Levels Strongly Predict Disease Flare in RA and Psa Patients with Low Disease Activity Treated with TNF Inhibitors. a One-Year Prospective Cohort Study

被引：0
|
作者：
Inciarte-Mundo, Jose [1 ]
Victoria Hernandez, M. [1 ]
Ruiz-Esquide, Virginia [1 ]
Cabrera-Villalba, Sonia [1 ]
Ramirez, Julio [1 ]
Cuervo, Andrea [1 ]
Pascal, Mariona [2 ]
Yague, Jordi [2 ]
Canete, Juan D. [1 ]
Sanmarti, Raimon [1 ]
机构：
[1] Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
651
引用
收藏
页数：2
相关论文
共 48 条
  • [21] Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study
    Perrotta, F. M.
    Delle Sedie, A.
    Scriffignano, S.
    Volpe, P.
    Cordisco, E.
    Milano, N.
    Gabini, M.
    Lubrano, E.
    REUMATISMO, 2020, 72 (01) : 52 - 59
  • [22] Prospective comparison of one-year survival in patients treated operatively and nonoperatively for spinal metastatic disease: results of the prospective observational study of spinal metastasis treatment (POST)
    Xiong, Grace X.
    Collins, Jamie E.
    Ferrone, Marco L.
    Schoenfeld, Andrew J.
    SPINE JOURNAL, 2023, 23 (01): : 14 - 17
  • [23] Does corticosteroid suppress the progression of disability in rheumatoid arthritis (RA) patients in low disease activity state? Studies in a prospective cohort study
    Iikuni, N.
    Inoue, E.
    Hara, M.
    Tomatsu, T.
    Kamatani, N.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 329 - 330
  • [24] COMPARATIVE STUDY ON THE PRESENCE OF ULTRASOUND SUBCLINICAL SYNOVITIS BETWEEN PATIENTS WITH RA AND PSA IN CLINICAL REMISSION OR LOW DISEASE ACTIVITY IN TREATMENT WITH ANTI-TNF THERAPY
    Ramirez Garcia, J.
    Inciarte-Mundo, J.
    Ruiz-Esquide, V.
    Cabrera, S.
    Celis, R.
    Cuervo, A.
    Saura, C.
    Canete, J. D.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 242 - 242
  • [25] "Continuous Reduction" in Serum RF Titers Predicts Low Disease Activity and Good Therapeutic Response in RA Patients Treated with TNF Inhibitors, but Does Not Relate to Clinical Outcomes during ABT Treatment
    Owada, Takayoshi
    Kurasawa, Kazuhiro
    Takamura, Yuta
    Miyao, Tomoyuki
    Tanaka, Ayae
    Yamazaki, Ryutaro
    Arai, Satoko
    Maezawa, Reika
    Arima, Masafumi
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [26] Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study
    Hao, Yanjie
    Ji, Lanlan
    Gao, Dai
    Fan, Yong
    Geng, Yan
    Zhang, Xiaohui
    Li, Guangtao
    Zhang, Zhuoli
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [27] Usefulness of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance Treatment With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study
    Ferreiro, Rocio
    Barreiro-de Acosta, M.
    Lorenzo-Gonzalez, Aurelio
    Dominguez-Munoz, Enrique
    GASTROENTEROLOGY, 2016, 150 (04) : S420 - S420
  • [28] Usefulness of consecutive faecal calprotectin measurements to predict relapse in inflammatory bowel disease patients under maintenance treatment with anti-TNF therapy: a prospective longitudinal cohort study
    Ferreiro, R.
    Barreiro-de Acosta, M.
    Lorenzo, A.
    Dominguez-Munoz, J. E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S147 - S147
  • [29] Calprotectin Serum Levels Reflect Residual Inflammatory Activity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis on Clinical Remission or Low Disease Activity Undergoing TNF-Antagonists Therapy.
    Inciarte-Mundo, Jose
    Victoria Hernandez, M.
    Cabrera-Villalba, Sonia
    Ramirez, Julio
    Cuervo, Andrea
    Ruiz-Esquide, Virginia
    Gonzalez Navarro, Azucena
    Yaguee, Jordi
    Canete, Juan D.
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1278 - S1279
  • [30] BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY
    Bertani, L.
    D'Antongiovanni, V
    Coppini, F.
    Benvenuti, L.
    Bronzini, F.
    Ceccarelli, L.
    Fornai, M.
    De Bortoli, N.
    Bellini, M.
    Antonioli, L.
    Costa, F.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S73 - S73
12345